• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.

作者信息

Seisen Thomas, Rouprêt Morgan, Blanchard Pierre

机构信息

GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpêtrière Hospital, Paris, France.

GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Pitié-Salpêtrière Hospital, Paris, France.

出版信息

Eur Urol. 2024 Jan;85(1):e24. doi: 10.1016/j.eururo.2023.07.019. Epub 2023 Aug 31.

DOI:10.1016/j.eururo.2023.07.019
PMID:37659960
Abstract
摘要

相似文献

1
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.回复：亚历山大·R·兹洛塔、莱斯利·K·巴拉斯、安杰伊·涅米尔科等人。根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：一项多机构倾向评分匹配和加权分析。《柳叶刀·肿瘤学》2023年；24卷：669 - 81页。
Eur Urol. 2024 Jan;85(1):e24. doi: 10.1016/j.eururo.2023.07.019. Epub 2023 Aug 31.
2
Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard's Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.对托马斯·塞森、摩根·鲁普雷、皮埃尔·布兰查德致编辑的信的回复，信的主题为：亚历山大·R·兹洛塔、莱斯利·K·巴拉斯、安杰伊·涅米尔科等人的《根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：多机构倾向评分匹配和加权分析》。《柳叶刀·肿瘤学》2023年；24卷：669 - 81页
Eur Urol. 2024 Jan;85(1):e25-e26. doi: 10.1016/j.eururo.2023.08.011. Epub 2023 Sep 1.
3
Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis.回复：根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：一项多机构倾向评分匹配及加权分析
Eur Urol. 2023 Dec;84(6):602-603. doi: 10.1016/j.eururo.2023.06.026. Epub 2023 Jul 12.
4
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌：多机构倾向评分匹配和加权分析。
Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12.
5
[Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer].[根治性膀胱切除术与三联疗法治疗肌层浸润性膀胱癌]
Strahlenther Onkol. 2023 Sep;199(9):871-873. doi: 10.1007/s00066-023-02134-1. Epub 2023 Aug 2.
6
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.根治性膀胱切除术或三联疗法治疗肌层浸润性膀胱癌：一项探索患者在做出治疗选择时的优先事项和咨询需求的定性研究。
BMC Cancer. 2024 Jan 31;24(1):160. doi: 10.1186/s12885-024-11927-1.
7
Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.铂类辅助化疗对肌层浸润性膀胱癌的疗效：加权倾向评分分析
Int J Urol. 2017 May;24(5):367-372. doi: 10.1111/iju.13324. Epub 2017 Mar 9.
8
Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.比较局部肌层浸润性膀胱癌患者行根治性与部分膀胱切除术的成本：了解外科治疗的价值。
Urology. 2021 Jan;147:127-134. doi: 10.1016/j.urology.2020.08.058. Epub 2020 Sep 24.
9
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply.根治性膀胱切除术与肌肉浸润性膀胱癌的三联疗法：仍需进一步广泛评估——作者回复
Lancet Oncol. 2023 Aug;24(8):e325-e326. doi: 10.1016/S1470-2045(23)00322-4.
10
Propensity score matched survival analysis of octogenarians with muscle-invasive bladder cancer: chemoradiation compared to radical cystectomy.80 岁及以上肌层浸润性膀胱癌患者的倾向评分匹配生存分析：放化疗与根治性膀胱切除术比较。
Can J Urol. 2023 Oct;30(5):11686-11691.